Report Detail

Chemical & Material Global Pharmaceutical Grade Cannabis Market Growth 2022-2028

  • RnM4452683
  • |
  • 10 June, 2022
  • |
  • Global
  • |
  • 121 Pages
  • |
  • LPI(LP Information)
  • |
  • Chemical & Material

As the global economy mends, the 2021 growth of Pharmaceutical Grade Cannabis will have significant change from previous year. According to our (LP Information) latest study, the global Pharmaceutical Grade Cannabis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pharmaceutical Grade Cannabis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Pharmaceutical Grade Cannabis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pharmaceutical Grade Cannabis market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Grade Cannabis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Pharmaceutical Grade Cannabis players cover Ultra Health, Mammoth Farms, Palo Verde Center, and Hexo Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Cannabis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Dronabinol
Nabilone
Nabiximols
Cannabidiol
Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oral Medications
Topical Medications

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Ultra Health
Mammoth Farms
Palo Verde Center
Hexo Corp
Bright Green Corporation
Copperstate Farms
Los Suenos Farms
Canna
Village Farms
Aurora
Canopy Growth
Cresco Labs
Glass House Farms
Organigram
C3 International
CannTrust
FlowerOne
Solaris Farms
7Acres
ThePharm


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Pharmaceutical Grade Cannabis Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Pharmaceutical Grade Cannabis by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Pharmaceutical Grade Cannabis by Country/Region, 2017, 2022 & 2028
  • 2.2 Pharmaceutical Grade Cannabis Segment by Type
    • 2.2.1 Dronabinol
    • 2.2.2 Nabilone
    • 2.2.3 Nabiximols
    • 2.2.4 Cannabidiol
    • 2.2.5 Other
  • 2.3 Pharmaceutical Grade Cannabis Sales by Type
    • 2.3.1 Global Pharmaceutical Grade Cannabis Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Pharmaceutical Grade Cannabis Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Pharmaceutical Grade Cannabis Sale Price by Type (2017-2022)
  • 2.4 Pharmaceutical Grade Cannabis Segment by Application
    • 2.4.1 Oral Medications
    • 2.4.2 Topical Medications
  • 2.5 Pharmaceutical Grade Cannabis Sales by Application
    • 2.5.1 Global Pharmaceutical Grade Cannabis Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Pharmaceutical Grade Cannabis Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Pharmaceutical Grade Cannabis Sale Price by Application (2017-2022)

3 Global Pharmaceutical Grade Cannabis by Company

  • 3.1 Global Pharmaceutical Grade Cannabis Breakdown Data by Company
    • 3.1.1 Global Pharmaceutical Grade Cannabis Annual Sales by Company (2020-2022)
    • 3.1.2 Global Pharmaceutical Grade Cannabis Sales Market Share by Company (2020-2022)
  • 3.2 Global Pharmaceutical Grade Cannabis Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Pharmaceutical Grade Cannabis Revenue by Company (2020-2022)
    • 3.2.2 Global Pharmaceutical Grade Cannabis Revenue Market Share by Company (2020-2022)
  • 3.3 Global Pharmaceutical Grade Cannabis Sale Price by Company
  • 3.4 Key Manufacturers Pharmaceutical Grade Cannabis Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Pharmaceutical Grade Cannabis Product Location Distribution
    • 3.4.2 Players Pharmaceutical Grade Cannabis Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pharmaceutical Grade Cannabis by Geographic Region

  • 4.1 World Historic Pharmaceutical Grade Cannabis Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Pharmaceutical Grade Cannabis Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Pharmaceutical Grade Cannabis Annual Revenue by Geographic Region
  • 4.2 World Historic Pharmaceutical Grade Cannabis Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Pharmaceutical Grade Cannabis Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Pharmaceutical Grade Cannabis Annual Revenue by Country/Region
  • 4.3 Americas Pharmaceutical Grade Cannabis Sales Growth
  • 4.4 APAC Pharmaceutical Grade Cannabis Sales Growth
  • 4.5 Europe Pharmaceutical Grade Cannabis Sales Growth
  • 4.6 Middle East & Africa Pharmaceutical Grade Cannabis Sales Growth

5 Americas

  • 5.1 Americas Pharmaceutical Grade Cannabis Sales by Country
    • 5.1.1 Americas Pharmaceutical Grade Cannabis Sales by Country (2017-2022)
    • 5.1.2 Americas Pharmaceutical Grade Cannabis Revenue by Country (2017-2022)
  • 5.2 Americas Pharmaceutical Grade Cannabis Sales by Type
  • 5.3 Americas Pharmaceutical Grade Cannabis Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Pharmaceutical Grade Cannabis Sales by Region
    • 6.1.1 APAC Pharmaceutical Grade Cannabis Sales by Region (2017-2022)
    • 6.1.2 APAC Pharmaceutical Grade Cannabis Revenue by Region (2017-2022)
  • 6.2 APAC Pharmaceutical Grade Cannabis Sales by Type
  • 6.3 APAC Pharmaceutical Grade Cannabis Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Pharmaceutical Grade Cannabis by Country
    • 7.1.1 Europe Pharmaceutical Grade Cannabis Sales by Country (2017-2022)
    • 7.1.2 Europe Pharmaceutical Grade Cannabis Revenue by Country (2017-2022)
  • 7.2 Europe Pharmaceutical Grade Cannabis Sales by Type
  • 7.3 Europe Pharmaceutical Grade Cannabis Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Pharmaceutical Grade Cannabis by Country
    • 8.1.1 Middle East & Africa Pharmaceutical Grade Cannabis Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Pharmaceutical Grade Cannabis Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Pharmaceutical Grade Cannabis Sales by Type
  • 8.3 Middle East & Africa Pharmaceutical Grade Cannabis Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Cannabis
  • 10.3 Manufacturing Process Analysis of Pharmaceutical Grade Cannabis
  • 10.4 Industry Chain Structure of Pharmaceutical Grade Cannabis

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Pharmaceutical Grade Cannabis Distributors
  • 11.3 Pharmaceutical Grade Cannabis Customer

12 World Forecast Review for Pharmaceutical Grade Cannabis by Geographic Region

  • 12.1 Global Pharmaceutical Grade Cannabis Market Size Forecast by Region
    • 12.1.1 Global Pharmaceutical Grade Cannabis Forecast by Region (2023-2028)
    • 12.1.2 Global Pharmaceutical Grade Cannabis Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Pharmaceutical Grade Cannabis Forecast by Type
  • 12.7 Global Pharmaceutical Grade Cannabis Forecast by Application

13 Key Players Analysis

  • 13.1 Ultra Health
    • 13.1.1 Ultra Health Company Information
    • 13.1.2 Ultra Health Pharmaceutical Grade Cannabis Product Offered
    • 13.1.3 Ultra Health Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Ultra Health Main Business Overview
    • 13.1.5 Ultra Health Latest Developments
  • 13.2 Mammoth Farms
    • 13.2.1 Mammoth Farms Company Information
    • 13.2.2 Mammoth Farms Pharmaceutical Grade Cannabis Product Offered
    • 13.2.3 Mammoth Farms Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Mammoth Farms Main Business Overview
    • 13.2.5 Mammoth Farms Latest Developments
  • 13.3 Palo Verde Center
    • 13.3.1 Palo Verde Center Company Information
    • 13.3.2 Palo Verde Center Pharmaceutical Grade Cannabis Product Offered
    • 13.3.3 Palo Verde Center Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Palo Verde Center Main Business Overview
    • 13.3.5 Palo Verde Center Latest Developments
  • 13.4 Hexo Corp
    • 13.4.1 Hexo Corp Company Information
    • 13.4.2 Hexo Corp Pharmaceutical Grade Cannabis Product Offered
    • 13.4.3 Hexo Corp Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Hexo Corp Main Business Overview
    • 13.4.5 Hexo Corp Latest Developments
  • 13.5 Bright Green Corporation
    • 13.5.1 Bright Green Corporation Company Information
    • 13.5.2 Bright Green Corporation Pharmaceutical Grade Cannabis Product Offered
    • 13.5.3 Bright Green Corporation Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Bright Green Corporation Main Business Overview
    • 13.5.5 Bright Green Corporation Latest Developments
  • 13.6 Copperstate Farms
    • 13.6.1 Copperstate Farms Company Information
    • 13.6.2 Copperstate Farms Pharmaceutical Grade Cannabis Product Offered
    • 13.6.3 Copperstate Farms Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Copperstate Farms Main Business Overview
    • 13.6.5 Copperstate Farms Latest Developments
  • 13.7 Los Suenos Farms
    • 13.7.1 Los Suenos Farms Company Information
    • 13.7.2 Los Suenos Farms Pharmaceutical Grade Cannabis Product Offered
    • 13.7.3 Los Suenos Farms Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Los Suenos Farms Main Business Overview
    • 13.7.5 Los Suenos Farms Latest Developments
  • 13.8 Canna
    • 13.8.1 Canna Company Information
    • 13.8.2 Canna Pharmaceutical Grade Cannabis Product Offered
    • 13.8.3 Canna Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Canna Main Business Overview
    • 13.8.5 Canna Latest Developments
  • 13.9 Village Farms
    • 13.9.1 Village Farms Company Information
    • 13.9.2 Village Farms Pharmaceutical Grade Cannabis Product Offered
    • 13.9.3 Village Farms Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Village Farms Main Business Overview
    • 13.9.5 Village Farms Latest Developments
  • 13.10 Aurora
    • 13.10.1 Aurora Company Information
    • 13.10.2 Aurora Pharmaceutical Grade Cannabis Product Offered
    • 13.10.3 Aurora Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Aurora Main Business Overview
    • 13.10.5 Aurora Latest Developments
  • 13.11 Canopy Growth
    • 13.11.1 Canopy Growth Company Information
    • 13.11.2 Canopy Growth Pharmaceutical Grade Cannabis Product Offered
    • 13.11.3 Canopy Growth Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Canopy Growth Main Business Overview
    • 13.11.5 Canopy Growth Latest Developments
  • 13.12 Cresco Labs
    • 13.12.1 Cresco Labs Company Information
    • 13.12.2 Cresco Labs Pharmaceutical Grade Cannabis Product Offered
    • 13.12.3 Cresco Labs Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Cresco Labs Main Business Overview
    • 13.12.5 Cresco Labs Latest Developments
  • 13.13 Glass House Farms
    • 13.13.1 Glass House Farms Company Information
    • 13.13.2 Glass House Farms Pharmaceutical Grade Cannabis Product Offered
    • 13.13.3 Glass House Farms Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Glass House Farms Main Business Overview
    • 13.13.5 Glass House Farms Latest Developments
  • 13.14 Organigram
    • 13.14.1 Organigram Company Information
    • 13.14.2 Organigram Pharmaceutical Grade Cannabis Product Offered
    • 13.14.3 Organigram Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Organigram Main Business Overview
    • 13.14.5 Organigram Latest Developments
  • 13.15 C3 International
    • 13.15.1 C3 International Company Information
    • 13.15.2 C3 International Pharmaceutical Grade Cannabis Product Offered
    • 13.15.3 C3 International Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 C3 International Main Business Overview
    • 13.15.5 C3 International Latest Developments
  • 13.16 CannTrust
    • 13.16.1 CannTrust Company Information
    • 13.16.2 CannTrust Pharmaceutical Grade Cannabis Product Offered
    • 13.16.3 CannTrust Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 CannTrust Main Business Overview
    • 13.16.5 CannTrust Latest Developments
  • 13.17 FlowerOne
    • 13.17.1 FlowerOne Company Information
    • 13.17.2 FlowerOne Pharmaceutical Grade Cannabis Product Offered
    • 13.17.3 FlowerOne Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.17.4 FlowerOne Main Business Overview
    • 13.17.5 FlowerOne Latest Developments
  • 13.18 Solaris Farms
    • 13.18.1 Solaris Farms Company Information
    • 13.18.2 Solaris Farms Pharmaceutical Grade Cannabis Product Offered
    • 13.18.3 Solaris Farms Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.18.4 Solaris Farms Main Business Overview
    • 13.18.5 Solaris Farms Latest Developments
  • 13.19 7Acres
    • 13.19.1 7Acres Company Information
    • 13.19.2 7Acres Pharmaceutical Grade Cannabis Product Offered
    • 13.19.3 7Acres Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.19.4 7Acres Main Business Overview
    • 13.19.5 7Acres Latest Developments
  • 13.20 ThePharm
    • 13.20.1 ThePharm Company Information
    • 13.20.2 ThePharm Pharmaceutical Grade Cannabis Product Offered
    • 13.20.3 ThePharm Pharmaceutical Grade Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.20.4 ThePharm Main Business Overview
    • 13.20.5 ThePharm Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Pharmaceutical Grade Cannabis. Industry analysis & Market Report on Pharmaceutical Grade Cannabis is a syndicated market report, published as Global Pharmaceutical Grade Cannabis Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Pharmaceutical Grade Cannabis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report